» Articles » PMID: 39720976

Arsenic Unsettles the Cerebellar Balance Between Neurodegeneration and Neurogenesis: Reversal by Folic Acid

Overview
Journal Apoptosis
Publisher Springer
Date 2024 Dec 25
PMID 39720976
Authors
Affiliations
Soon will be listed here.
Abstract

Arsenic-mediated neurodegenerative disorders affect millions of individuals globally, but the specific impact of environmental arsenic on adult cerebellar degeneration and neurogenesis is incompletely understood. Of particular concern is arsenic-induced apoptosis-driven neurodegeneration. Our major objective was to investigate the molecular signaling intricacies associated with arsenic-induced death of cerebellar neurons and to propose folic acid as a possible intervention. Swiss albino mice were treated with sodium arsenite (orally: 0.05 mg/L) and folic acid (orally:10 mg/kg) for 28 days. We observed that arsenic caused noticeable cell loss with morphological alterations in cerebellum, which was remarkably restored by folic acid. Arsenic-induced morphological alterations consequently perturbed transcriptional activities of neural stem cell factors-SOX2 and KLF9, which resulted in the suppression of pro-neurogenic mediators NeuroD1, Neurogenin2, calbindin and NeuN. Interestingly, folic acid reversed the expression of these critical pro-neurogenic mediators to mitigate these degenerative changes to promote neurogenesis. Delving deep, we found that folic acid rescued arsenic-exposed cerebellum from severe oxidative and pro-inflammatory insults by increasing antioxidants like SOD, Catalase, GSH, upregulating Nrf2 and downregulating M1 macrophages, JNK, NF-κB, and STAT3 activities. For the first time, we are reporting that arsenic induced a G1/S cell cycle arrest and triggered apoptosis in mouse cerebellum by activating the p53-p21 axis, downregulating CDKs and instigated p21-mediated suppression of SOX2 transcriptional activity. Folic acid abated such alterations by modulating the p53/p21/SOX2 axis. Collectively, the anti-apoptotic and pro-neurogenic effects of folic acid present it as a promising therapeutic candidate, warranting further research into its efficacy against metal-induced neurodegenerative disorders.

References
1.
Muzaffar S, Khan J, Srivastava R, Gorbatyuk M, Athar M . Mechanistic understanding of the toxic effects of arsenic and warfare arsenicals on human health and environment. Cell Biol Toxicol. 2022; 39(1):85-110. PMC: 10042769. DOI: 10.1007/s10565-022-09710-8. View

2.
Sanchez-Pena L, Petrosyan P, Morales M, Gonzalez N, Gutierrez-Ospina G, Del Razo L . Arsenic species, AS3MT amount, and AS3MT gene expression in different brain regions of mouse exposed to arsenite. Environ Res. 2010; 110(5):428-34. DOI: 10.1016/j.envres.2010.01.007. View

3.
Tyler C, Allan A . The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review. Curr Environ Health Rep. 2014; 1:132-147. PMC: 4026128. DOI: 10.1007/s40572-014-0012-1. View

4.
Tolins M, Ruchirawat M, Landrigan P . The developmental neurotoxicity of arsenic: cognitive and behavioral consequences of early life exposure. Ann Glob Health. 2014; 80(4):303-14. DOI: 10.1016/j.aogh.2014.09.005. View

5.
Thakur M, Rachamalla M, Niyogi S, Datusalia A, Flora S . Molecular Mechanism of Arsenic-Induced Neurotoxicity including Neuronal Dysfunctions. Int J Mol Sci. 2021; 22(18). PMC: 8471829. DOI: 10.3390/ijms221810077. View